Find out how Geistlich Bio-Oss®, vallos® and Geistlich Bio-Gide® can simplify your regenerative procedures and request your Trial Observation Program now.

Sign up now!

Discover the trusted foundation for successful bone regeneration.

Your patients trust you – and you can always rely on Geistlich to deliver the best-in-class patient outcomes with Geistlich Bio-Oss®, vallos® and Geistlich Bio-Gide®: the ideal biomaterials for new bone.  

Contact our experts!

Higher implant survival starts with Geistlich Bio-Oss®.

Get closer to the bone with Geistlich Bio-Oss® – the original natural bone substitute. Achieve brilliant results, even in challenging cases. Geistlich Bio-Oss® matches the quality and strength of natural bone5, offers excellent handling, and ensures consistent performance in daily clinical use. 

  • Easy application across a wide range of indications 
  • Long-term bone volume stability with minimal resorption13 
  • Outstanding implant esthetics and functionality when combined with Geistlich Bio-Gide®9 
Request a free trial!
Request a free trial!

vallos®: A dental allograft that sets the pace for regeneration.

As a leader in oral regeneration, Geistlich understands that in certain clinical situations, rapid turnover of bone is important. With our comprehensive allograft portfolio, vallos® provides you the optimal allograft scaffold to meet a variety of regenerative needs.  

  • Single source supplier ensures consistent product quality14
  • A full portfolio offering that includes, granules, fibers, demineralized, mineralized and blended allografts
  • Stringent donor selection and proprietary aseptic processing that protects the native integrity of the graft
  • Comprised of 100% bone
  • No synthetic carriers added  

Geistlich Bio-Gide®: Reliable bone regeneration, optimal tissue integration.

Achieve better patient outcomes and greater augmentation success. Even if wound healing complications arise, Geistlich Bio-Gide® – the original collagen membrane – continues to protect the grafted site,15 making it the trusted choice for predictable bone regeneration and long-term success.  

  • Exceptional strength, flexibility, and barrier function16,17,18 
  • Simplified surgeries – no need to remove the membrane 
  • Optimal tissue integration and wound stabilization12,19,20 
  • 11% more new bone formation with Geistlich Bio-Oss® and Geistlich Bio-Gide® vs Geistlich Bio-Oss® alone9  
Request a free trial!

Request Your Trial Observation Program* 

Test Geistlich Bio-Oss®, vallos® & Geistlich Bio-Gide® and experience the benefits of our regenerative solutions with support from our experts. Your dedicated Geistlich Regenerative Specialist will be by your side, offering guidance and expertise every step of the way.

*Terms and Conditions: Valid July 1–December 31, 2025. Each trial is limited to a total of 4 units of biomaterial, of which one unit can be GEM 21S. Only valid for new customers or a new product category to existing customers. Qualifications determined at Geistlich’s discretion. Excludes Yxoss, RPM, Meta, and McBio products. Not applicable for Dental Service Organizations, Government, and Military Accounts. Submission and feedback form must be submitted for qualification. The user agrees to have the Geistlich Regenerative Specialist observe the surgery and post-surgery survey.

Interesting facts about Geistlich

  1. iDATA Global Market Report Suite for Dental GL Bone Graft Substitutes and Other Biomaterials, June 2024 
  2. Search conducted on 05.05.2025 in the internal library. Reference list available upon request. 
  3. iData Research Inc., US Dental Bone Graft Substitutes and other Biomaterials Market, 2021. 
  4. iData Research Inc., European Dental Bone Graft Substitutes and other Biomaterials Market, 2021. 
  5. Data on file. 
  6. Jung RE, et al., Clin Oral Implants Res. 2021 Dec;32(12):1455-1465. (clinical study) 
  7. Benic GI, et al., J Clin Periodontol. 2017 Mar;44(3):315-325. (clinical study) 
  8. Chappuis V, et al., J Dent Res. 2018 Mar;97(3):266-274. (clinical study) 
  9. Perelman-Karmon M, et al., Int J Periodontics Restorative Dent. 2012 Aug;32(4):459-65. (clinical study) 
  10. Tal H, et al., Clin Oral Implants Res 2008; 19 (3), 295-302. (clinical study) 
  11. Knöfler W, et al., Int J Implant Dent. 2016 Dec;2(1):25. (clinical study) 
  12. Rothamel D, et al., Clin Oral Implants Res 2005; 16 (3), 369-78. (pre-clinical study) 
  13. Mordenfeld A, et al., Clin Oral Implants Res. 2010 Sep;21(9):961-70. (clinical study) 
  14. Data on file, MTF Biologics
  15. Dinato TR, et al., J Clin Exp Dent. 2024 Sep 1;16(9):e1110-e1119. (clinical study) 
  16. Data on file. 
  17. Urban IA et al.: Int J Periodontics Restorative Dent 2013; 33 (3), 299-307. 
  18. Rothamel D et al.: Clin Oral Implants Res 2005; 16 (3), 369-78. 
  19. Schwarz F et al. Clin. Oral Implants Res. 2006;17(4):403-409. (Pre-clinical study) 
  20. Schwarz F et al. Clin. Oral Implants Res. 2008;19(4): 402-415. (Pre-clinical study)